期刊文献+

Fas siRNA真核表达载体构建及其抑制Jurkat细胞凋亡的作用

Construction of Fas Targeting siRNA-expressing Vector and Its Apoptotic Inhibitory Effect
下载PDF
导出
摘要 目的构建Fas(CD95)特异性siRNA真核表达载体psilencircle-FasSi,转染Fas-FasL凋亡敏感细胞株Jurkat,研究其抗凋亡作用。方法通过聚合酶链式反应(PCR)制备siRNA表达框架(SECs),转染Jurkat细胞,实时荧光定量PCR检测FasmRNA抑制率,筛选出高效抑制FasmRNA表达的siRNA;把筛选出的siRNA序列插入siRNA真核表达质粒psilencircle,构建psilencircle-Fas-Si;psilecircle-FasSi转染Jurkat细胞,实时荧光定量PCR检测FasmRNA、Westernblot检测Fas蛋白;anti-FasmAb刺激Jurkat细胞凋亡,流式细胞术检测Jurkat细胞凋亡率。结果酶切、测序证明成功构建了psilecircle-FasSi,实时荧光定量PCR及Westernblot表明psilencircle-FasSi可抑制FasmRNA和蛋白表达,流式细胞术检测证实psilencircle-FasSi可抑制Jurkat凋亡率。结论我们成功构建了Fas特异性siRNA真核表达载体psilencircle-FasSi,它不仅可以下调Jurkat细胞的Fas表达而且可以显著抑制Fas-FasL途径诱导的凋亡。 Objective To construct Fas-targeting siRNA expressing vector,to transfect Fas-FasL sensitive Jurkat cell line and to study its anti-apoptotic effect.Methods The siRNA expression cassettes (SECs)are generated by PCR,then Jurkat cells were transfected by Fas targeting SECs.The efficient SEC was selected by comparison of Fas mRNA level using real time fluorescent quantitative PCR (FQ-PCR)and construct the psilecircle-FasSi SEC.Fas expression of Jurkat cells transfected by psilencircle-FasSi(Jurkat-FasSi)was analyzed by FQ-PCR and Western blot.Jurkat-FasSi was treated by anti-Fas mAb to induce apoptosis and apoptotic rate was detected by flow cytometry.Results Restriction enzyme digestion analysis and the sequence analysis confirmed that the psilecircle-FasSi was successfully constructed.FQ-PCR and Western blot results showed that Fas expression in Jurkat-FasSi cells was down-regulated.Flow cytometry analysis using Annexin/PI staining indicated that apoptosis induced by anti-Fas antibody in Jurkat-FasSi cells was significantly inhibited.Conclusion The Fas siRNA eukaryotic expression plasmid(psilencircle-FasSi)was successfully constructed.It can down-regulate Fas expression by transfected it into Jurkat cell line and inhibited Fas-FasL pathway induced apoptosis significantly through RNAi.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第9期979-983,共5页 Cancer Research on Prevention and Treatment
基金 湖北省教育厅自然科学研究资助项目(Q200513003) 湖北省卫生厅科研基金指导性项目(JX2C30)
关键词 SIRNA FAS 真核表达载体 细胞凋亡 siRNA Fas Eukaryotic expression vector Apoptosis
  • 相关文献

参考文献7

  • 1Li JH, Rosen D, Sondel P, et al. Immune privilige and FasL: two ways to inactive effector cytotoxic T lymphocytes by FasL- expressing cells[J]. Immunology, 2002,1{15 (3) : 267-277.
  • 2Yiu SM, Wong PW, Lam TW, et al. Filtering of ineffective siRNAs and improved siRNA design tool[J]. Bioinformatics, 2005,21(2) : 144-151.
  • 3Sakakibara Y, Popendorf K, Ogawa N,et al. Stem kernels for RNA sequence analyses[J].J Bioinform Comput Biol, 2007,5 (5):1103-1122.
  • 4张中华,侯永泰.siRNA制备技术的研究进展[J].生命科学,2004,16(4):231-235. 被引量:12
  • 5Livak KJ,Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2E - Delta Delta C(T)3 Method[J]. Methods, 2001,25(4) 402-408.
  • 6Kim K, Lee K, Hong YS, et al. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells[J].Exp Mol Med, 2000,32(4) :246-254.
  • 7陈复兴,李玺.肿瘤的细胞免疫治疗[J].国外医学(免疫学分册),2004,27(4):197-202. 被引量:25

二级参考文献39

  • 1Kikuchi T, Akasaki Y, Irie M, et al.Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells[J].Cancer Immunol Immunother,2001,50:337-344.
  • 2Roskrow BMA, Suzuki N, Gan YJ, et al.Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of patients with FBV-positive relapsed Hodgkin's disease[J].Blood, 1998,91 (8) :2925-2934.
  • 3Sykulev Y, Joo M, Vturina I, et al.Evidence that a single peptide-MHC complex on a target cell can licit A cytolytic T cell response[ J ].Immunity, 1996,4: 565-571.
  • 4Lum LG, Iefever AV,Treisman JS, et al.Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-coactivated T cellsphase I clinical trial[J] .J Immunother,2001,24(5) :408-419.
  • 5Ito F, Cart A, Svenssson H, et al.Antitumor reactivity of anti-CD3/antiCD28 bead-activated lymphoid cells: implications for cell therapy in a murine model [ J ].J Immunother, 2003,26 (3): 222-233.
  • 6lwashita Y, Tahara K, Goto S, et al.A phase I study of autologus dendritic cell-based immunotherapy for patients with unresectable primaryliver cancer[ J ].Cancer Immunol Immunother, 2003,52:155-161.
  • 7Yu JS, Wheeler CJ, Zeltyer PM, et al.Vaccination of malignant galioma patients with peptide-pulsed dendritic cells elicits system cytotoxity and Tcell infiltration[J].Cancer Res,2001,61(3) :842-847.
  • 8Holmers LM, Li JH, Sticca RP, et al.A padid, novel strategy to induce tumor cell-spccific cytotoxic T lymphocyte responses using instant dendritomas[J] .J Immunother,2001,24(2): 122-129.
  • 9Kugler A, Stuhleer G, Walden P, et al.Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrics[J].Nat Med,2000,6:332-336.
  • 10Marten A, Grten T, Ziske C, et al.Generation of activated and antigenspecific T cells with cytotoxic activity after co-culture with dendritic cells[J].Cancer Immunol Immunother,2002,51:25-32.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部